An immune-competent lung-on-a-chip for modelling the human severe influenza infection response
{{output}}
Severe influenza affects 3-5 million people worldwide each year, resulting in more than 300,000 deaths annually. However, standard-of-care antiviral therapeutics have limited effectiveness in these patients. Current preclinical models of severe influenza fail ... ...
